Tag Archives: Quinine
Herbal/Vitamin Supplement Industry – Good or Bad?
On some interesting news I read a few months ago, Pfizer’s (a major pharmaceutical company) patent on its impotence drug Viagra has been partially rejected after the U.S. Patent and Trademark Office (USPTO) said it wasn’t different enough from a … Continue reading →
Posted in BioTech/Pharma, Business
|
Tagged Bayer, Cardioquin, Cephaelis, Cialis, Cinchona, Crystodigin, Digitalis, Dr. Christine Daniel, dysentery, Eli Lilly, Eli Lilly and Company, erectile dysfunction, FDA, Foxglove, heart conditions, horny goat weed, icariin, Ipecacuanha, Lanoxin, Levitra, malaria, Pfizer, pharmaceutical, Plasmodium falciparum, Quin-Release, Quinaglute Dura-tabs, Quinidex Extentabs, Quinine, United States Patent and Trademark Office, USPTO, Viagra, yin yang huo
|
Leave a comment